• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Pharma industry news

farydak

EC approves multiple myeloma treatment Farydak

4 September 2015

The EC has approved Farydak in combination with bortezomib and dexamethasone for the treatment of patients with relapsed and/or refractory multiple myeloma...

roactemra

NICE recommends RoActemra for severe rheumatoid arthritis

4 September 2015

RoActemra has been recommended by NICE for the treatment of patients with severe rheumatoid arthritis whose disease has not responded to intensive therapy with a combination of cDMARDs...

brilinta

FDA approves label expansion for AstraZeneca’s Brilinta

4 September 2015

The FDA has approved Brilinta tablets at a new 60mg dose to be used in patients with a history of heart attack beyond the first year...

ace910

FDA grants breakthrough therapy designation to Roche’s ACE910

4 September 2015

Breakthrough therapy designation has been granted to ACE910 for the prophylactic treatment of people with haemophilia A with factor VIII inhibitors...

aquesys

Allergan to acquire glaucoma treatment company AqueSys

4 September 2015

Allergan is to acquire AqueSys for a $300 million upfront payment and milestone payments related to AqueSys' lead development programmes, including XEN45...

acs-heart

Branded ACS therapies to grab market share from generic drugs

4 September 2015

While generic acute coronary syndrome (ACS) drugs currently lead in market revenues, the share of branded therapeutics is expected to increase to more than 60% of the total market by 2019...

pharmaceutical-sector

Extent of data breaches in pharmaceutical sector revealed

3 September 2015

The extent of data breaches in the pharmaceutical sector has been revealed by a survey that reveals 60% have lost important data...

whooping-cough

PHE calls for pregnant woman to have whooping cough vaccine

3 September 2015

PHE is calling for pregnant women to take up the whooping cough vaccine as surveillance figures confirm that whooping cough activity remains at raised levels in England...

apremilast

NICE does not recommend apremilast for psoriatic arthritis

3 September 2015

NICE has published final draft guidance which does not recommend apremilast, saying that there is not enough evidence to demonstrate apremilast slows progression of psoriatic arthritis...

etelcalcetide

Amgen submits MAA for etelcalcetide to the EMA

3 September 2015

If approved, etelcalcetide will be the first calcimimetic agent that can be administered intravenously for the treatment of SHPT in patients with chronic kidney disease...

kremers-urban

UCB to sell Kremers Urban to Lannett

3 September 2015

Lannett Company has entered into a definitive agreement to acquire UCB’s US generics subsidiary, Kremers Urban Pharmaceuticals, for $1.23 billion...

iclaprim

FDA grants Fast Track designation to iclaprim

3 September 2015

The FDA has granted Fast Track designation to iclaprim to treat acute bacterial skin and skin structure infections and hospital acquired bacterial pneumonia...